Having trouble accessing articles? Reset your cache.

Macoven Pharmaceuticals LLC, Pernix Therapeutics deal

Pernix acquired partner Macoven for $2.2 million in cash,

Read the full 90 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE